BioCentury | Sep 26, 2016
Clinical News

EGEN-001: Phase Ib ongoing

...DMSB recommended continuation to the fourth and last cohort of the open-label, U.S. Phase Ib OVATION...
BioCentury | Aug 15, 2016
Clinical News

EGEN-001: Additional Phase Ib data

...or primary peritoneal cancer in the first 2 cohorts of the open-label, U.S. Phase Ib OVATION...
BioCentury | Jun 6, 2016
Clinical News

EGEN-001: Phase Ib data

...diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer in the open-label, U.S. Phase Ib OVATION...
...79 and 103 mg/m 2 intraperitoneal GEN-1 for 8 weeks plus a taxane and carboplatin. OVATION’s...
BioCentury | Oct 19, 2015
Clinical News

EGEN-001: Phase Ib started

...Celsion began the open-label, dose-escalation, U.S. Phase Ib OVATION Study to evaluate intraperitoneal GEN-1 with standard...
BioCentury | Sep 10, 2015
Tools & Techniques

Undiscovered country

...RNA sequencing method is sensitive enough to detect gene fusions. In 2014, NuGen launched the Ovation...
BioCentury | Dec 9, 2013
Clinical News

Onfi clobazam regulatory update

...in patients ages >=2 years. The pharma gained the 1,5-benzodiazepine through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Nov 4, 2013
Clinical News

Sabril vigabatrin regulatory update

...Aug. 24, 2009). Lundbeck has North American rights to Sabril through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Aug 19, 2013
Company News

Lundbeck sales and marketing update

...projected average Onfi dose per day. The pharma gained Onfi through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Dec 17, 2012
Clinical News

Sabril vigabatrin neurology data

...and infantile spasms. Lundbeck has North American rights to Sabril through its 2009 acquisition of Ovation Pharmaceuticals Inc. WIR...
BioCentury | Jan 9, 2012
Company News

Lundbeck sales and marketing update

...10 and 20 mg tablet, respectively. The pharma gained Onfi through its 2009 acquisition of Ovation Pharmaceuticals Inc....
Items per page:
1 - 10 of 121
BioCentury | Sep 26, 2016
Clinical News

EGEN-001: Phase Ib ongoing

...DMSB recommended continuation to the fourth and last cohort of the open-label, U.S. Phase Ib OVATION...
BioCentury | Aug 15, 2016
Clinical News

EGEN-001: Additional Phase Ib data

...or primary peritoneal cancer in the first 2 cohorts of the open-label, U.S. Phase Ib OVATION...
BioCentury | Jun 6, 2016
Clinical News

EGEN-001: Phase Ib data

...diagnosed epithelial ovarian, fallopian tube or primary peritoneal cancer in the open-label, U.S. Phase Ib OVATION...
...79 and 103 mg/m 2 intraperitoneal GEN-1 for 8 weeks plus a taxane and carboplatin. OVATION’s...
BioCentury | Oct 19, 2015
Clinical News

EGEN-001: Phase Ib started

...Celsion began the open-label, dose-escalation, U.S. Phase Ib OVATION Study to evaluate intraperitoneal GEN-1 with standard...
BioCentury | Sep 10, 2015
Tools & Techniques

Undiscovered country

...RNA sequencing method is sensitive enough to detect gene fusions. In 2014, NuGen launched the Ovation...
BioCentury | Dec 9, 2013
Clinical News

Onfi clobazam regulatory update

...in patients ages >=2 years. The pharma gained the 1,5-benzodiazepine through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Nov 4, 2013
Clinical News

Sabril vigabatrin regulatory update

...Aug. 24, 2009). Lundbeck has North American rights to Sabril through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Aug 19, 2013
Company News

Lundbeck sales and marketing update

...projected average Onfi dose per day. The pharma gained Onfi through its 2009 acquisition of Ovation Pharmaceuticals Inc....
BioCentury | Dec 17, 2012
Clinical News

Sabril vigabatrin neurology data

...and infantile spasms. Lundbeck has North American rights to Sabril through its 2009 acquisition of Ovation Pharmaceuticals Inc. WIR...
BioCentury | Jan 9, 2012
Company News

Lundbeck sales and marketing update

...10 and 20 mg tablet, respectively. The pharma gained Onfi through its 2009 acquisition of Ovation Pharmaceuticals Inc....
Items per page:
1 - 10 of 121